EDGAR Filing Documents for 0001193125-21-106316

Form 8-K - Current report:

SEC Accession No. 0001193125-21-106316

Filing Date

2021-04-05

Accepted

2021-04-05 16:05:03

Documents

Period of Report

2021-04-02

Items

Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d81863d8k.htm	8-K	21692
2	EX-3.1	d81863dex31.htm	EX-3.1	141424
3	EX-99.1	d81863dex991.htm	EX-99.1	12092
4	EX-99.2	d81863dex992.htm	EX-99.2	19486
	Complete submission text file	0001193125-21-106316.txt		196054

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306

Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676

Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 21805332
SIC: 2834 Pharmaceutical Preparations